Ligand Pharmaceuticals Incorporated (LGND)

Ligand Pharmaceuticals Revenue

In the year 2025, Ligand Pharmaceuticals had annual revenue of $268.09M with 60.40% growth. Ligand Pharmaceuticals had revenue of $59.67M in the quarter ending December 31, 2025, with 39.37% growth.

• Revenue (ttm): $268.09M
• Revenue Growth: +60.40%
• P/S Ratio: 15.19
• Revenue / Employee: $3,942,456
• Employees: 68
• Market Cap: 4.07B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	268.09M	100.95M	60.40%
Dec 31, 2024	167.13M	35.82M	27.28%
Dec 31, 2023	131.31M	-64.93M	-33.09%
Dec 31, 2022	196.25M	-45.30M	-18.75%
Dec 31, 2021	241.54M	77.98M	47.68%
Dec 31, 2020	163.56M	43.28M	35.98%
Dec 31, 2019	120.28M	-131.17M	-52.17%
Dec 31, 2018	251.45M	110.35M	78.21%
Dec 31, 2017	141.10M	32.13M	29.48%
Dec 31, 2016	108.97M	37.06M	51.53%
Dec 31, 2015	71.91M	7.38M	11.43%
Dec 31, 2014	64.54M	15.57M	31.78%
Dec 31, 2013	48.97M	17.59M	56.02%
Dec 31, 2012	31.39M	1.35M	4.50%
Dec 31, 2011	30.04M	6.50M	27.61%
Dec 31, 2010	23.54M	-15.40M	-39.55%
Dec 31, 2009	38.94M	11.63M	42.56%
Dec 31, 2008	27.32M	14.42M	111.84%
Dec 31, 2007	12.89M	8.92M	224.21%
Dec 31, 2006	3.98M	-6.24M	-61.07%
Dec 31, 2005	10.22M	-	-